These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8787954)

  • 1. Prognostic factors in the intellectual development at 7 years of age in children with congenital hypothyroidism.
    Salerno M; Di Maio S; Militerni R; Argenziano A; Valerio G; Tenore A
    J Endocrinol Invest; 1995 Nov; 18(10):774-9. PubMed ID: 8787954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
    Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
    Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of lower L-thyroxine dose for treatment of congenital hypothyroidism.
    Campos SP; Sandberg DE; Barrick C; Voorhess ML; MacGillivray MH
    Clin Pediatr (Phila); 1995 Oct; 34(10):514-20. PubMed ID: 8591677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intellectual development in children with congenital hypothyroidism in relation to recommended thyroxine treatment.
    Heyerdahl S; Kase BF; Lie SO
    J Pediatr; 1991 Jun; 118(6):850-7. PubMed ID: 2040919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the screening program for congenital hypothyroidism in Berlin (1978-1995).
    Grüters A; Liesenkötter KP; Zapico M; Jenner A; Dütting C; Pfeiffer E; Lehmkuhl U
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():28-31. PubMed ID: 9439911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier onset of treatment or increment in LT4 dose in screened congenital hypothyroidism: which as the more important factor for IQ at 7 years?
    Boileau P; Bain P; Rives S; Toublanc JE
    Horm Res; 2004; 61(5):228-33. PubMed ID: 15115051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between biochemical severity and intelligence in early treated congenital hypothyroidism: a threshold effect.
    Tillotson SL; Fuggle PW; Smith I; Ades AE; Grant DB
    BMJ; 1994 Aug; 309(6952):440-5. PubMed ID: 7920127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intellectual outcome of patients with congenital hypothyroidism detected by neonatal screening.
    Hsiao PH; Chiu YN; Tsai WY; Su SC; Lee JS; Soong WT
    J Formos Med Assoc; 2001 Jan; 100(1):40-4. PubMed ID: 11265259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of L-thyroxine replacement therapy in children with congenital hypothyroidism.
    Chiovato L; Giusti L; Tonacchera M; Ciampi M; Mammoli C; Lippi F; Lapi P; Bargagna S; Dini P; Ferretti G
    J Endocrinol Invest; 1991 Dec; 14(11):957-64. PubMed ID: 1806614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults.
    Oerbeck B; Sundet K; Kase BF; Heyerdahl S
    Pediatrics; 2003 Oct; 112(4):923-30. PubMed ID: 14523187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean High-Dose l-Thyroxine Treatment Is Efficient and Safe to Achieve a Normal IQ in Young Adult Patients With Congenital Hypothyroidism.
    Aleksander PE; Brückner-Spieler M; Stoehr AM; Lankes E; Kühnen P; Schnabel D; Ernert A; Stäblein W; Craig ME; Blankenstein O; Grüters A; Krude H
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1459-1469. PubMed ID: 29325045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with congenital hypothyroidism: long-term intellectual outcome after early high-dose treatment.
    Dimitropoulos A; Molinari L; Etter K; Torresani T; Lang-Muritano M; Jenni OG; Largo RH; Latal B
    Pediatr Res; 2009 Feb; 65(2):242-8. PubMed ID: 18787501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia in infants with congenital hypothyroidism diagnosed by neonatal screening.
    Franzese A; Salerno M; Argenziano A; Buongiovanni C; Limauro R; Tenore A
    J Endocrinol Invest; 1996 Oct; 19(9):613-9. PubMed ID: 8957746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological follow-up in early-treated congenital hypothyroidism: a problem-oriented approach.
    Bargagna S; Canepa G; Costagli C; Dinetti D; Marcheschi M; Millepiedi S; Montanelli L; Pinchera A; Chiovato L
    Thyroid; 2000 Mar; 10(3):243-9. PubMed ID: 10779139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical hypothyroidism in pregnancy: intellectual development of offspring.
    Behrooz HG; Tohidi M; Mehrabi Y; Behrooz EG; Tehranidoost M; Azizi F
    Thyroid; 2011 Oct; 21(10):1143-7. PubMed ID: 21943136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intellectual outcome at 12 years of age in congenital hypothyroidism.
    Salerno M; Militerni R; Di Maio S; Bravaccio C; Gasparini N; Tenore A
    Eur J Endocrinol; 1999 Aug; 141(2):105-10. PubMed ID: 10427151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism.
    Fisher DA; Schoen EJ; La Franchi S; Mandel SH; Nelson JC; Carlton EI; Goshi JH
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2722-7. PubMed ID: 10946871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment variables as predictors of intellectual outcome in children with congenital hypothyroidism.
    Heyerdahl S
    Eur J Pediatr; 1996 May; 155(5):357-61. PubMed ID: 8741030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment.
    Dubuis JM; Glorieux J; Richer F; Deal CL; Dussault JH; Van Vliet G
    J Clin Endocrinol Metab; 1996 Jan; 81(1):222-7. PubMed ID: 8550756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring.
    Albert BB; Heather N; Derraik JG; Cutfield WS; Wouldes T; Tregurtha S; Mathai S; Webster D; Jefferies C; Gunn AJ; Hofman PL
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3663-70. PubMed ID: 23861458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.